Recruiting

NorMIGS - a Study of Micro-invasive Glaucoma Surgery

NorMIGS is a non-randomized clinical study of intraocular pressure lowering effect and complications after Preserflo microshunt implantation versus other types of glaucoma surgery. The study is conducted in the Department of Ophthalmology, Oslo University Hospital, Norway.

ClinicalTrials.gov IDNCT05340647
PhaseNot Applicable
Enrollment100
SponsorOslo University Hospital
Age18 Years
SexALL
I'm interested View official listing

Conditions studied

Glaucoma

About this study

NorMIGS is a non-randomized clinical study of intraocular pressure lowering effect and complications after Preserflo microshunt implantation versus other types of glaucoma surgery. The study is conducted in the Department of Ophthalmology, Oslo University Hospital, Norway.

Interventions

Primary outcomes

Eligibility information

Inclusion Criteria: * Patients must be 18 years or older at the time of signing the informed consent form. There is no upper age limit. * Scheduled for implantation of Preserflo microshunt, trabeculectomy or other types of MIGS * Ability to cooperate fairly well during the examinations * Willing to participate in the study and capable of providing informed consent Exclusion Criteria: \- High intraocular pressure due to increased episcleral venous pressure, hemorrhagic glaucoma, traumatic glaucoma or uveitis glaucoma

Study locations

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.